Mechanistic Insight into Poly-Reactivity of Immune Antibodies upon Acid Denaturation or Arginine Mutation in Antigen-Binding Regions.
acid conformation
domain
flexibility
molten globule
poly-reactivity
Journal
Antibodies (Basel, Switzerland)
ISSN: 2073-4468
Titre abrégé: Antibodies (Basel)
Pays: Switzerland
ID NLM: 101587489
Informations de publication
Date de publication:
13 Oct 2023
13 Oct 2023
Historique:
received:
08
08
2023
revised:
03
10
2023
accepted:
06
10
2023
medline:
24
10
2023
pubmed:
24
10
2023
entrez:
24
10
2023
Statut:
epublish
Résumé
The poly-reactivity of antibodies is defined as their binding to specific antigens as well as to related proteins and also to unrelated targets. Poly-reactivity can occur in individual molecules of natural serum antibodies, likely due to their conformation flexibility, and, for therapeutic antibodies, it plays a critical role in their clinical development. On the one hand, it can enhance their binding to target antigens and cognate receptors, but, on the other hand, it may lead to a loss of antibody function by binding to off-target proteins. Notably, poly-reactivity has been observed in antibodies subjected to treatments with dissociating, destabilizing or denaturing agents, in particular acidic pH, a common step in the therapeutic antibody production process involving the elution of Protein-A bound antibodies and viral clearance using low pH buffers. Additionally, poly-reactivity can emerge during the affinity maturation in the immune system, such as the germinal center. This review delves into the underlying potential causes of poly-reactivity, highlighting the importance of conformational flexibility, which can be further augmented by the acid denaturation of antibodies and the introduction of arginine mutations into the complementary regions of antibody-variable domains. The focus is placed on a particular antibody's acid conformation, meticulously characterized through circular dichroism, differential scanning calorimetry, and sedimentation velocity analyses. By gaining a deeper understanding of these mechanisms, we aim to shed light on the complexities of antibody poly-reactivity and its implications for therapeutic applications.
Identifiants
pubmed: 37873861
pii: antib12040064
doi: 10.3390/antib12040064
pmc: PMC10594486
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Mol Biol. 2003 Dec 5;334(4):733-49
pubmed: 14636599
Biophys J. 2000 Jan;78(1):394-404
pubmed: 10620303
Autoimmun Rev. 2008 Jun;7(6):431-4
pubmed: 18558357
Protein Sci. 2017 Nov;26(11):2162-2169
pubmed: 28791742
Cell Host Microbe. 2007 Mar 15;1(1):51-61
pubmed: 18005681
Protein Sci. 1997 Feb;6(2):422-30
pubmed: 9041645
Nat Commun. 2019 Feb 8;10(1):654
pubmed: 30737386
J Autoimmun. 2001 Mar;16(2):163-72
pubmed: 11247642
MAbs. 2021 Jan-Dec;13(1):1999195
pubmed: 34780320
Int J Mol Sci. 2019 Sep 09;20(18):
pubmed: 31505894
FEBS Lett. 1995 Mar 20;361(2-3):173-5
pubmed: 7698318
Sci Rep. 2015 May 05;5:9803
pubmed: 25940394
Autoimmun Rev. 2008 Jun;7(6):410-4
pubmed: 18558353
FEBS J. 2010 Jul;277(14):3039-50
pubmed: 20546303
J Pharm Sci. 2009 Sep;98(9):3013-30
pubmed: 18680168
J Biol Chem. 1971 Apr 10;246(7):2211-7
pubmed: 5555568
J Immunol Methods. 2000 Jul 31;241(1-2):1-10
pubmed: 10915844
Antibodies (Basel). 2023 Mar 16;12(1):
pubmed: 36975371
J Infect Dis. 2015 Jul 15;212 Suppl 1:S42-6
pubmed: 26116731
Annu Rev Biophys Biomol Struct. 1995;24:495-522
pubmed: 7663125
J Membr Biol. 2011 Jan;239(1-2):49-56
pubmed: 21107547
Scand J Immunol. 2016 Apr;83(4):227-34
pubmed: 26808310
Proteins. 2007 Mar 1;66(4):954-62
pubmed: 17154421
J Phys Chem Lett. 2023 Apr 27;14(16):3898-3906
pubmed: 37093025
Trends Immunol. 2004 Apr;25(4):174-9
pubmed: 15039043
Methods Mol Biol. 2014;1060:79-110
pubmed: 24037837
iScience. 2023 May 25;26(6):106957
pubmed: 37332605
J Autoimmun. 2007 Dec;29(4):213-8
pubmed: 17888629
J Mol Biol. 2008 Apr 11;377(5):1518-28
pubmed: 18336836
Biochim Biophys Acta. 1999 Apr 12;1431(1):120-31
pubmed: 10209285
Biophys Chem. 2007 Apr;127(1-2):1-8
pubmed: 17257734
Cell. 1999 Nov 12;99(4):421-31
pubmed: 10571184
Mol Immunol. 2007 Mar;44(8):1854-63
pubmed: 17097144
Antibodies (Basel). 2018 Apr 19;7(2):
pubmed: 31544870
J Mol Biol. 2001 Jun 22;309(5):1077-85
pubmed: 11399080
Protein Eng Des Sel. 2018 Nov 1;31(11):409-418
pubmed: 30770934
Nat Rev Immunol. 2019 Jun;19(6):355-368
pubmed: 30718829
Adv Protein Chem. 1995;47:83-229
pubmed: 8561052
Biomolecules. 2020 Mar 06;10(3):
pubmed: 32155758
J Pharm Sci. 2018 Nov;107(11):2965-2967
pubmed: 30017886
Biochemistry. 1993 Oct 5;32(39):10351-8
pubmed: 8399178
Int J Biol Macromol. 2021 Feb 1;169:28-38
pubmed: 33340621
Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):84-9
pubmed: 22171009
Eur J Immunol. 1998 Jul;28(7):2108-14
pubmed: 9692879
J Immunol. 1990 Dec 1;145(11):3807-13
pubmed: 2246515
J Biol Chem. 2017 Oct 6;292(40):16638-16652
pubmed: 28778924
Eur J Biochem. 1982 Sep 1;126(3):517-21
pubmed: 7140745
Biochemistry. 1990 Apr 10;29(14):3480-8
pubmed: 2162192
Protein Expr Purif. 2018 Jun;146:27-33
pubmed: 29378261
J Mol Biol. 1998 Jul 3;280(1):1-9
pubmed: 9653027
Biochemistry. 1991 Jul 16;30(28):6922-9
pubmed: 1906346
Anal Chim Acta. 2008 Sep 5;625(1):103-9
pubmed: 18721546
Eur J Biochem. 1991 Oct 1;201(1):223-32
pubmed: 1915367
Antibodies (Basel). 2023 Feb 13;12(1):
pubmed: 36810520
MAbs. 2013 May-Jun;5(3):432-44
pubmed: 23608772
Structure. 2004 Mar;12(3):409-15
pubmed: 15016357
Biochemistry. 1994 Dec 20;33(50):15178-89
pubmed: 7999778
Acc Chem Res. 2013 Apr 16;46(4):885-93
pubmed: 23214924
Biokhimiia. 1996 Feb;61(2):212-35
pubmed: 8717493